In this infographic we take a look at the diagnostics currently in the pipeline for tuberculosis, highlighting the stage of development and intended use.
We take a look at the key microbiome therapeutics currently in the clinical pipeline for recurrent C. difficile infections and their prospects for the treatment of this disease in the future.
In our latest infographic we provide a visual snapshot of the infections and immune processes that have been linked with the microbiome thus far, explaining some of the evidence
In a recent study published in Nature Communications, researchers validated a novel screening approach to identify host-directed compounds that reduce the replication of intracellular pathogens, Julie Kaiser explains.
The end of January saw the London Centre for Neglected Tropical Disease Research’s (LCNTDR; UK) annual anniversary event, this year commemorating the sixth anniversary of the London Declaration on Neglected Tropical Diseases (NTDs). Discover more about the research presented in this report.
Infectious diseases remain a major cause of mortality across the globe, so if pathogens could therefore be harnessed as a weapon, the implications would certainly be severe and far-reaching. Find out more about biothreats and bioterrorism in our explainer.
In a recent study published in Nature Communications, researchers demonstrated that acquired resistance to the polymixin antibiotic, colistin, can be detrimental to bacterial survival, revealing unique evolutionary trade-offs of this new form of resistance.
Want to find out what’s been happening this year? Editor, Martha Powell, highlights the best of 2017’s infectious diseases research in an A–Z.